ArticleBMC biology2025
Machine learning combined with omics-based approaches reveals T-lymphocyte cellular fate imbalance in abdominal aortic aneurysm.
Article in BMC biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Identification and Validation of Plasma Protein Biomarkers for Abdominal Aortic Aneurysm Using Integrated Proteomics.International journal of molecular sciences · 2026Article
- Multi-omics integration study of vascular smooth muscle cell phenotypic conversion identified novel biomarkers in idiopathic pulmonary arterial hypertension.Respiratory research · 2026Article
- Macrophage-derived CCL20-CCR6 signaling as a driver of immune recruitment in abdominal aortic aneurysm.Frontiers in immunology · 2026Article
- Microarray Analysis of Human Abdominal Aortic Aneurysm With Emphasis on Cardiovascular Genes Revealed Differentially Expressed Genes.In vivo (Athens, Greece)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
Abstract
backgroundAbdominal aortic aneurysm (AAA) is typically an asymptomatic disease closely associated with immune mechanisms. A deep understanding of cellular responses within AAA tissues, particularly the molecular changes in T-cell populations, is critical for disease diagnosis and treatment. However, the specific mechanisms inducing T-lymphocyte fate imbalance in AAA remain to be elucidated.
resultsThe analysis revealed the core mechanisms driving T-lymphocyte fate imbalance in AAA. We successfully established a comprehensive regulatory map encompassing T-cell infiltration regulatory features, critical transcription factors, and dysregulated immune signaling pathways. Machine learning algorithms identified transcription factors FOSB and JUNB as key biomarkers. Validation across multiple independent datasets and clinical samples confirmed the feasibility and accuracy of FOSB and JUNB as clinical diagnostic biomarkers for AAA.
conclusionsThrough the analysis of single-cell and bulk data, hallmarks of human AAA cellular landscape and T-cell comprehensive developmental relationships were recapitulated. This study identified important roles of T-cell and the molecular mechanisms for the dynamic T-cell infiltrating process, which could characterize disease status and landscape of human AAA microenvironment. Using the deep learning algorithms, FOSB and JUNB were demonstrated as pivotal biomarkers of AAA, together with screening the potential pharmacologic agents targeting T-cell polarization. Taken together, this expands the current understanding of AAA pathogenesis and may provide a feasible immune-targeted therapeutic strategy.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.